hivandhepatitis.com

Error
  • Article not found
Complete Coverage of the 2012 International Liver Congress

Complete Coverage of the 2012 International Liver Congress

HIVandHepatitis.com coverage of the 2012 International Liver Congress -- 47th Annual Meeting of the European Association for the Study of the Liver (EASL), April 18-22.

Conference highlights include experimental hepatitis C therapies, interferon-free regimens, boceprevir (Victrelis) and telaprevir (Incivek/Incivo) in real-world practice, difficult-to-treat patients, HIV/HCV coinfection, hepatitis B research, and liver cancer research.

Full listing by topic

HIVandHepatitis.com EASL 2012 conference s...

READ MORE...

HIV Infection Associated with Increased Risk of Sudden Cardiac Death

HIV Infection Associated with Increased Risk of Sudden Cardiac Death

This Friday, May 18, is HIV Vaccine Awareness Day (HVAD) in the U.S. as well as World AIDS Vaccine Day, an opportunity to raise awareness about the importance of preventive HIV vaccine research and to recognize the many study volunteers, community advocates, health professionals, and researchers who are working to find safe and effective vaccines to reduce the risk of HIV infection.

READ MORE...

EASL: Ribavirin Dose Reduction Is Effective for Managing Anemia in Patients Using Boceprevir or Telaprevir

EASL: Ribavirin Dose Reduction Is Effective for Managing Anemia in Patients Using Boceprevir or Telaprevir

Reducing the dose of ribavirin and adding erythropoietin are both good options for managing anemia in hepatitis C patients treated with boceprevir (Victrelis) triple therapy, according to study findings presented at the 47th International Liver Congress (EASL 2012) this week in Barcelona. A related study found that ribavirin reduction also did not impair cure rates with telaprevir (Incivek).

READ MORE...

Professional Tattooing and Piercing Not Linked to Hepatitis C Risk

Professional Tattooing and Piercing Not Linked to Hepatitis C Risk

While amateur tattoos and other body modifications done in prison or other non-professional settings can carry an increased risk of acquiring hepatitis C virus (HCV), there is no evidence of increased transmission risk for tattoos or piercings done in professional studios, according to a meta-analysis described in the April 15, 2012 issue of Clinical Infectious Diseases .

READ MORE...

Complete Coverage of the 2012 Conference on Retroviruses and Opportunistic Infections

Complete Coverage of the 2012 Conference on Retroviruses and Opportunistic Infections

HIVandHepatitis.com's complete coverage of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), March 5-8, 2012.

Featuring new HIV drugs, HIV cure research, biomedical prevention, HIV-related conditions and complications, basic science, hepatitis C, and HIV/HCV coinfection.

Full listing by topic

HIVandHepatitis.com CROI 2012 section

 

READ MORE...

1 of 5 Loading
Federal Syringe Access Policy: Where Are We Now?

Federal Syringe Access Policy: Where Are We Now?

May 18 is HIV Vaccine Awareness Day

May 18 is HIV Vaccine Awareness Day

FDA Advisory Committee Recommends Truvada for Prevention of HIV Sexual Transmission

FDA Advisory Committee Recommends Truvada for Prevention of HIV Sexual Transmission

FDA Advisors Favor Approval of 4-in-1 Elvitegravir Quad Pill for HIV

FDA Advisors Favor Approval of 4-in-1 Elvitegravir Quad Pill for HIV

Long-Term Analysis Confirms Elevated HIV Risk for Some Participants in Step Vaccine Study

Long-Term Analysis Confirms Elevated HIV Risk for Some Participants in Step Vaccine Study

Ribavirin Helps Early Hepatitis C Treatment in People with HIV

Ribavirin Helps Early Hepatitis C Treatment in People with HIV

Researchers Identify Compounds that May Block HPV's Ability to Cause Cancer

Researchers Identify Compounds that May Block HPV's Ability to Cause Cancer

HIV/AIDS

Setting

HIV Treatment

HIV Gene Therapy Shows Long-term Safety and Activity after 11 Years

Genetically modified T-cells engineered to attack HIV were still present and sho...

MORE:

HIV Prevention

FDA Committee Will Consider Approval of Truvada for HIV PrEP this Thursday

On May 10, 2012, the Antiviral Drugs Advisory Committee of the U.S. Food and Dru...

MORE:

HIV Testing & Diagnosis

Oral HIV Tests May Be Less Accurate than Blood Tests

Oral HIV antibody testing is quick and convenient, but this method is not quite ...

MORE:

HIV Policy & Advocacy

ACT UP at 25

The AIDS Coalition to Unleash Power, better known as ACT UP, held its first majo...

MORE:

Hepatitis B

Setting

HBV Treatment

EASL: Telbivudine Effective for Hepatitis B Patients Selected with Roadmap

Telbivudine (Tyzeka) is an effective treatment for chronic hepatitis B with mini...

MORE:

HBV Prevention

CDC Advisory Committee Recommends Hepatitis B Vaccine for People with Diabetes

The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immun...

MORE:

HBV Testing & Diagnosis

Interpreting Hepatitis B Tests

The following table from the U.S. Centers for Disease Control and Prevention (CD...

MORE:

HBV Disease Progression

EASL: Brivanib Did Not Improve Overall Liver Cancer Survival, but Did Show Anti-tumor Activity

The experimental cancer drug brivanib did not lengthen overall survival for pati...

MORE:

Hepatitis C

Setting

HCV Treatment

EASL: MicroRNA Miravirsen Looks Safe and Effective for Genotype 1 Hepatitis C

Miravirsen, the first microRNA therapy for hepatitis C, was well-tolerated and d...

MORE:

HCV Prevention

Scientists Find Antibodies that Neutralize Multiple Strains of Hepatitis C Virus

As described in a report published in the April 4, 2012, online edition of Proceed...

MORE:

HCV Testing & Diagnosis

AASLD: HCV Screening of 1945-1965 Birth Cohort Appears Cost-Effective

Screening all people in the U.S. in the 46 to 66 year age group for hepatitis C ...

MORE:

Side Effects - HCV

Anemia during Hepatitis C Treatment Predicts Sustained Response to Pegylated Interferon/ribavirin

Hepatitis C patients who develop anemia during treatment with pegylated int...

Coinfection

Setting

HIV/HBV Coinfection

CROI: Detectable HIV Raises Risk of Incomplete Hepatitis B Suppression

HIV/HBV coinfected people with detectable HIV viral load and higher baseline HBV...

MORE:

HIV/HCV Coinfection

EASL: Boceprevir Improves Cure Rates for HIV/HCV Coinfection but Beware of Drug Interactions

Adding boceprevir (Victrelis) to pegylated interferon and ribavirin for treatmen...

MORE:

Other Infections

Setting

Tuberculosis (TB)

March 24 is World TB Day

Tuberculosis (TB) is the leading cause of death for people with HIV worldwide --...

MORE:

Other STDs

Researchers Report Setbacks on Herpes Simplex Vaccine and Treatment

An experimental herpes simplex virus (HSV) vaccine partially protected women aga...

MORE:

Human Papillomavirus (HPV)

AASLD: High Rate of Cancer-Causing HPV among Women with Hepatitis C Awaiting Liver Transplants

Nearly 1 in 5 women undergoing liver transplantation -- most of them due to chro...

MORE:

Hepatitis A & E

Hepatitis E Uncommon among HIV+ People, but May Cause Unexplained Liver Enzyme Elevations

Coinfection with hepatitis E virus (HEV) is not commonly seen in people with HIV...

MORE:
Copyright © 2012 hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.